Loading…
Loading…
PIAHY does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for PIAHY and 80,000+ other tickers.
See exactly how PIAHY's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for PIAHY and 80,000+ other tickers.
Established in 2014 and based in Shanghai, China, Ping An Healthcare and Technology Company Limited manages a comprehensive online platform for healthcare services across the People's Republic of China. The company provides a wide array of offerings, including virtual medical consultations, assistance with hospital referrals and appointments, inpatient care coordination, and access to second medical opinions. It also develops standardized consumer health service packages that integrate various healthcare institutions. Furthermore, Ping An supplies healthcare products such as pharmaceuticals…
I upgrade Ping An Healthcare to a Buy due to favorable expectations of upcoming earnings and a vote of confidence from its parent. My prediction is that PIAHY will deliver its first-ever positive net profit when it releases FY24 results next week. Ping An Insurance recently increased its equity interest in PANHF to over 50%; this bodes well for the latter's outlook, considering potential collaboration opportunities.
HONG KONG and SHANGHAI , Nov. 7, 2024 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", "Ping An Health", or "the Company", Stock Code: 1833.HK) established a strategic partnership with Medtronic (Shanghai) Management Co., Ltd. ("Medtronic") at the 7th China International Import Expo (CIIE) held at the National Exhibition and Convention Center (Shanghai) on 6 November, 2024.